PULSE NEWS WIRE
Clear, Actionable Intelligence
<2 min
Avg Latency
24/5
Coverage
Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on February 2, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: February 02, 2026 Perseus Proteomics Inc. [4882.T] TOKYO, Feb 02 (Pulse News Wire) – Perseus Proteomics Inc. (4882.T) reported the monthly exercise status of warrant shares issued on January 05, 2026. In January, one warrant was exercised out of a total issuance of 36,800 warrants, resulting in the delivery of 100 shares. As of January 05, 2026, there were 36,800 unexercised warrants, which decreased to 36,799 by month-end. The exercise price for the warrant was s